Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohortLoreta A. Kondili, Federica Romano, Francesca Romana Rolli et al.|Hepatology|2017Cited by 29